Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: c.hinton who wrote (1485)	8/10/2008 11:02:32 AM
From: TimF	Read Replies (2) \| Respond to of 3816

tim do you believe all their profit comes from america. No one said anything about all their profit. I said they sell drugs in the US. Since they make a lot of profit in the US, it doesn't matter much if the company is based in Europe, the US, or elsewhere. Large companies being based in Europe does nothing to indicate that the way European's (and Canadians and others) treat the drug companies in terms of forcing prices down, can make for a health drug industry with well funded research, development, and testing programs. you are trapped in the view the rest of the world is a paracite sucking americas blood. That's a bit too strong, but the reality is at least in that direction. The US is about 5% of the world's population and just over 20% of the world's gross production, but about 48% of world drug revenue. The higher prices the US pays effectively subsidizes R&D + testing for new drugs for the rest of the world.